These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28504970)

  • 1. Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.
    McConnell M; Feng S; Chen W; Zhu G; Shen D; Ponnazhagan S; Deng L; Li YP
    Oncotarget; 2017 Jul; 8(29):47675-47690. PubMed ID: 28504970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis.
    Feng S; Zhu G; McConnell M; Deng L; Zhao Q; Wu M; Zhou Q; Wang J; Qi J; Li YP; Chen W
    Int J Biol Sci; 2013; 9(8):853-62. PubMed ID: 24155661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atp6v1c1 may regulate filament actin arrangement in breast cancer cells.
    Cai M; Liu P; Wei L; Wang J; Qi J; Feng S; Deng L
    PLoS One; 2014; 9(1):e84833. PubMed ID: 24454753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
    Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
    Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology.
    Li S; Hao L; Wang L; Lu Y; Li Q; Zhu Z; Shao JZ; Chen W
    PLoS One; 2015; 10(8):e0134903. PubMed ID: 26274612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curbing Breast Cancer by Altering V-ATPase Action on F-Actin, Heterochromatin, ETV7 and mTORC2 Signaling.
    Khan ZS; Hussain F
    Cell Physiol Biochem; 2024 Jun; 58(3):250-272. PubMed ID: 38865588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma.
    Yao X; Chen H; Xu B; Lu J; Gu J; Chen F; Ju M; Sun X
    Gene; 2021 Feb; 768():145261. PubMed ID: 33183740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness.
    McGuire C; Cotter K; Stransky L; Forgac M
    Biochim Biophys Acta; 2016 Aug; 1857(8):1213-1218. PubMed ID: 26906430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 Silencing Attenuates Inflammation and Alveolar Bone Resorption in Endodontic Disease.
    Wang Y; Chen W; Hao L; McVicar A; Wu J; Gao N; Liu Y; Li YP
    J Endod; 2019 Jul; 45(7):898-906. PubMed ID: 31104818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
    Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
    Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.
    Wang A; Carraro-Lacroix LR; Owen C; Gao B; Corey PN; Tyrrell P; Brumell JH; Voronov I
    Sci Rep; 2017 Jun; 7(1):3005. PubMed ID: 28592812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.
    McGuire CM; Collins MP; Sun-Wada G; Wada Y; Forgac M
    J Biol Chem; 2019 Jul; 294(29):11248-11258. PubMed ID: 31167791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer.
    Fan SH; Wang YY; Wu ZY; Zhang ZF; Lu J; Li MQ; Shan Q; Wu DM; Sun CH; Hu B; Zheng YL
    Oncotarget; 2015 Jul; 6(21):18406-17. PubMed ID: 26110566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase.
    Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M
    Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VD
    Santos JM; Hussain F
    J Nutr Biochem; 2019 Aug; 70():185-193. PubMed ID: 31229911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.
    Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Zhang ZF; Shan Q; Hu B; Li MQ; Cheng W
    J Cell Biochem; 2015 Apr; 116(4):502-13. PubMed ID: 25213553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.
    Strazic-Geljic I; Guberovic I; Didak B; Schmid-Antomarchi H; Schmid-Alliana A; Boukhechba F; Bouler JM; Scimeca JC; Verron E
    Biochem Pharmacol; 2016 Sep; 116():11-21. PubMed ID: 27378505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis.
    Hinz N; Baranowsky A; Horn M; Kriegs M; Sibbertsen F; Smit DJ; Clezardin P; Lange T; Schinke T; Jücker M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33670586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.